+44 (0) 1698 534002
Contact

News

BioAscent appoints new CEO and announces plans to expand discovery services offering

12 July 2017

NEWHOUSE, UK (11 July 2017): BioAscent Discovery Limited (www.bioascent.com) has announced the appointment of Paul Smith...

Read more

The Revival of a Compound Management Facility

04 May 2015

Aaron Sutherland and Steven Russell will explain at Titian Users Group Meeting on 20-21 May in London how recommissionin...

Read more

Accelerating Drug Discovery Innovation

17 October 2014

Compound collections are a valuable corporate asset capable of being utilised to promote and drive innovation in early-s...

Read more

Drug Discovery Open Innovation: Maximising Diversity of Shared Compound Collections

08 October 2014

Considering embarking on an innovation-driven collaboration involving your compound collection?— How can you be sure you...

Read more

BioAscent on front cover of EBR Journal

08 October 2014

We’re excited that our lab automation features on the front cover of this month’s European Biopharmaceutical Review.

Read more

Compound Collection Sharing: A New Model of Drug Discovery Innovation

06 April 2014

The sharing of corporate compound collections was until recently very challenging.However last year’s successful creatio...

Read more

BioAscent is Compound Management “Centre of Excellence” for IMI European Lead Factory

01 January 2013

BioAscent have been selected as the Compound Logistics “Centre of Excellence” for the IMI European Lead Factory (ELF), a...

Read more

Integrated Drug Discovery

Science-led drug discovery

Compound Management

Connecting and accelerating your drug discovery

Medicinal Chemistry

Proven expertise in design and synthesis

In Silico Discovery

Accelerating drug design with computational expertise

Discovery Biology

Screening expertise across target classes

Get in Touch

Let's talk about how we can maximise your drug discovery success.

Contact